secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-02-15T23:59:59+00:00
Accession:  0001171520-22-000133
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports Q4 rev $4.3M (+15% YoY); FY2021 rev record $16.3M (+27% YoY); 2022 guidance $20-22M
--------------------------------------------------------------------------------

- Q4 2021 revenue $4.3M, up 15% YoY; functional neurosurgery products $2.1M (+37%), biologics/drug delivery $1.7M (+10%).
- Full-year 2021 record revenue $16.3M (+27% YoY) and record case volume 929 (+36% YoY), within initial guidance of $16-17.5M.
- Cash and equivalents $54.1M at year-end; management states no need for additional capital in 2022.
- 2022 revenue guidance $20-22M, representing growth of 23-35% YoY; COVID variant risk cited as key factor.
- Earnings call scheduled for March 1, 2022 after market close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000133/0001171520-22-000133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000133/eps10071_clpt.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer